Chen C-Q, Wang X, Zhang J, Zhu S-M
Department of Anesthesiology, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China.
Eur Rev Med Pharmacol Sci. 2017 Feb;21(3):627-634.
Anesthetic management of patients with dilated cardiomyopathy (DCM) is a challenge to the anesthesiologist, due to poor left systolic function, ventricular enlargement, risk of malignant arrhythmias and sudden cardiac death. Therefore, preoperative assessment and appropriate anesthetic management are important in patients with DCM. This review describes the preoperative evaluation and anesthesia considerations of patients with DCM undergoing non-cardiac surgery. Patient pathophysiology and clinical status, such as ventricular function, degree of myocardial fibrosis, resting heart rate and high-sensitivity C-reactive protein can affect survival rates. Advanced monitoring devices, such as transesophageal echocardiography and cardiac resynchronization therapy can be used to assess ventricular function and myocardial fibrosis. Thoracic epidural blockade can improve ventricular function. In summary, the optimal anesthetic management of patients with dilated cardiomyopathy requires good preoperative assessment, close perioperative monitoring, suitable anesthetic, optimization fluid management, and stable hemodynamic status.
扩张型心肌病(DCM)患者的麻醉管理对麻醉医生来说是一项挑战,这是由于左心室收缩功能差、心室扩大、恶性心律失常风险及心源性猝死风险所致。因此,术前评估及恰当的麻醉管理对DCM患者很重要。本综述描述了接受非心脏手术的DCM患者的术前评估及麻醉注意事项。患者的病理生理学及临床状况,如心室功能、心肌纤维化程度、静息心率及高敏C反应蛋白,会影响生存率。可使用高级监测设备,如经食管超声心动图及心脏再同步化治疗来评估心室功能及心肌纤维化。胸段硬膜外阻滞可改善心室功能。总之,扩张型心肌病患者的最佳麻醉管理需要良好的术前评估、围手术期密切监测、合适的麻醉、优化的液体管理及稳定的血流动力学状态。